News

November 09th, 2018

MedDay Pharmaceuticals Announces Full Patient Enrollment for MD1003 Phase III Clinical Trial (SPI2) in Progressive Multiple Sclerosis
Read more

July 26th, 2018

MedDay Appoints Industry Leader Christian Chavy as Chief Executive Officer
Read more

October 18th, 2017

MedDay to Participate in the 7th Joint ECTRIMS – ACTRIMS Meeting in Paris, France
Read more

September 18th, 2017

MedDay Pharmaceuticals GmbH to participate at the 90th Congress of the German Society of Neurology in Leipzig, Germany
Read more
See all recent news
Events
October 10 2018

MedDay attends the 34th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Berlin, Germany

September 27 2018

MedDay attends the 31st congress of "Association des Neurologues Libéraux de Langue française" (ANLLF) in Rennes, France

June 16 2018

MedDay attends the 4th congress of the European Academy of Neurology (EAN) in Lisbon, Portugal

May 30 2018

MedDay attends the 2018 Consortium of Multiple Sclerosis Centers (CMSC) Meeting in Nashville, Tennessee

April 21 2018

MedDay attends the 70th annual American Academy of Neurology (AAN) Meeting in Los Angeles, California

See all events